Insidersinvested$26.5mMino-Lokis our leadassetI won't diluteshareholdersWe willhaveexclusivityI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.I'm ashareholdermyselfWe expect tofinish theMino-Loktrial this yearHemorrhoidsis a $2BmarketThere are noFDAapproveddrugs to treathemorrhoidsI/ONTAKwas thebest deal Iever madeOur Halo-Lido trial willhave finalpatient byend of 2022We intendto submita BLA in2H 2022Only biotechwith 2 Myron'son theleadershipteamI/ONTAK'spotentialmarket is>$300mWe had aphase 2btrial with100%efficacyMyron Holubiakand I founded aprivatecompany in2013An actualiMSCupdateThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"Mino-Lokpotentialmarket>$1BWe will openupinternationalsites forMino-Lok trialI/Ontak isour leadassetNot manycompaniesthis size with2 late stageassetsWe haveenough cashto go wellinto 2023Mino-WrapInsidersinvested$26.5mMino-Lokis our leadassetI won't diluteshareholdersWe willhaveexclusivityI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.I'm ashareholdermyselfWe expect tofinish theMino-Loktrial this yearHemorrhoidsis a $2BmarketThere are noFDAapproveddrugs to treathemorrhoidsI/ONTAKwas thebest deal Iever madeOur Halo-Lido trial willhave finalpatient byend of 2022We intendto submita BLA in2H 2022Only biotechwith 2 Myron'son theleadershipteamI/ONTAK'spotentialmarket is>$300mWe had aphase 2btrial with100%efficacyMyron Holubiakand I founded aprivatecompany in2013An actualiMSCupdateThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"Mino-Lokpotentialmarket>$1BWe will openupinternationalsites forMino-Lok trialI/Ontak isour leadassetNot manycompaniesthis size with2 late stageassetsWe haveenough cashto go wellinto 2023Mino-Wrap

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
B
2
I
3
G
4
I
5
N
6
G
7
B
8
O
9
I
10
I
11
B
12
O
13
G
14
N
15
N
16
O
17
B
18
O
19
G
20
B
21
G
22
I
23
O
24
N
  1. B-Insiders invested $26.5m
  2. I-Mino-Lok is our lead asset
  3. G-I won't dilute shareholders
  4. I-We will have exclusivity
  5. N-I/ONTAK was previously approved but taken off the market to improve manufacturing.
  6. G-I'm a shareholder myself
  7. B-We expect to finish the Mino-Lok trial this year
  8. O-Hemorrhoids is a $2B market
  9. I-There are no FDA approved drugs to treat hemorrhoids
  10. I-I/ONTAK was the best deal I ever made
  11. B-Our Halo-Lido trial will have final patient by end of 2022
  12. O-We intend to submit a BLA in 2H 2022
  13. G-Only biotech with 2 Myron's on the leadership team
  14. N-I/ONTAK's potential market is >$300m
  15. N-We had a phase 2b trial with 100% efficacy
  16. O-Myron Holubiak and I founded a private company in 2013
  17. B-An actual iMSC update
  18. O-The name Citius comes from the Olympic motto "Citius,Altius Forius"
  19. G-Mino-Lok potential market >$1B
  20. B-We will open up international sites for Mino-Lok trial
  21. G-I/Ontak is our lead asset
  22. I-Not many companies this size with 2 late stage assets
  23. O-We have enough cash to go well into 2023
  24. N-Mino-Wrap